This federal Project Grant award of $752,991 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program supports a comprehensive study to understand the socioecological factors impacting disparities in early childhood sleep health. The project aims to evaluate the effects of understudied risk factors like racism, housing insecurity, screen media use, and toxic stress on child sleep health, as well as assess how socio-cultural,...
This Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), will fund the development and testing of a technology-based intervention to improve sleep self-management for adults with subarachnoid hemorrhage (SAH). The $1,408,372 grant will support tailoring an existing sleep intervention to the unique needs of SAH survivors, converting it to a digital format, and assessing its usability, feasibility, and acceptability....
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Lumostech, Inc. under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a smart sleep mask and mobile application to improve sleep for adolescents. The one-year project will apply light flash technology delivered through a sleep mask to advance teenagers' circadian phases without disrupting daytime activities. Cognitive behavioral therapy delivered via mobile...
This Project Grant award of $696,470 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to investigate how prenatal maternal sleep patterns influence pathways to cardiovascular disease risk in children. The project aims to examine three key pathways: maternal biological processes (stress and inflammation), child biological processes (growth and adiposity), and child behavior (sleep, emotionality,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), seeks to validate a novel multi-sensor machine learning approach for precision sleep tracking in nightshift workers. The $678,710 award will be used to compare the performance of this multi-sensor system to legacy actigraphy algorithms, and evaluate the feasibility and user experience of the system in a real-world, at-home...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to evaluate a telehealth-delivered adaptive intervention that promotes continuous positive airway pressure (CPAP) adherence and improves health outcomes for adults newly diagnosed with obstructive sleep apnea (OSA). The $1,415,112 award will fund a research study to compare the effects of motivational enhancement, device...
This federal Project Grant award of $332,862.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, will support research to assess night-to-night variability in novel sleep disordered breathing severity metrics and their impact on daytime functioning. The study aims to characterize reliable biomarkers of obstructive sleep apnea (OSA) severity, as the current standard measure (Apnea-Hypopnea Index) underestimates...
This Project Grant award of $133,410 from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the relationship between sleep quality, sleep apnea, and cardiac aging. The study aims to leverage longitudinal sleep data from the Korean Genome and Epidemiology Study to assess how impaired sleep patterns accelerate cardiovascular disease risk over a 12-year period. The research will focus on...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will evaluate the use of mobile devices to extract vital signs to monitor patients with asthma. The $459,127 award to M5 Enterprise, LLC (doing business as Emedical Sentry) aims to improve the detection and management of asthma attacks through remote patient monitoring. The goal is to enhance telehealth by incorporating video-based vital sign...
This $128,047 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of an innovative urine-based diagnostic test for obstructive sleep apnea (OSA). The grant recipient, PGXL Technologies LLC, is a minority-owned for-profit company collaborating with the University of Louisville Research Foundation to create a non-invasive urine assay that can detect OSA through a panel of...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,602,357 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to KDH Research & Communication, Inc., a woman-owned small business located in Atlanta, GA. The grant funds the development and evaluation of the "Personalized Approach to Habits-Sleep" (PATH-S) mobile app, which aims to improve sleep duration and asthma symptoms for Black teenagers aged 14-17 with asthma.
The PATH-S app will use gamification and intermittent reinforcement to encourage participants to adopt personalized healthy sleep habits. Key features include the ability for users to learn about healthy sleep, create a personalized sleep plan, track their progress, and report asthma symptoms. The app will sync with Fitbit devices to monitor sleep metrics. This Phase I project will involve gathering input from an expert advisory committee, developing and user-testing the minimum viable product, and conducting a feasibility study. The ultimate goal is to commercialize the PATH-S app by selling to third-party payers and expanding it to support other audiences at risk for sleep problems.